Partnering

Compounding for growth

Contact us

Press releases

| 05 July 2022

Fagron expands its US sterile compounding footprint with East coast acquisition

Fagron, the leading global player in pharmaceutical compounding, has acquired from Fresenius Kabi a 503B outsourcing facility in Boston.

Read more

Fagron

Our story

Together with prescribers and pharmacists, Fagron strives to improve personalized medicine and to make it (more) accessible for patients. In this way, we aim to have a significant impact on the health and welfare of people.

Read more

Partnering

Our process

A continuous focus on innovation, quality and efficiency is essential in consolidating our leading market positions. We start by exploring if our values are aligned for a potential partnership.

Our Process

Fagron

Our group

Fagron is active in 35 countries in EMEA, North America, and Latin America.

Fagron group

Partnering

Contact us

We are always keen to get learn more about you. Please fill in the contact form, send an email or call us.

Let’s connect

What we look for

Partnerships with companies that create value in healthcare by offering products and services for compounding personalized medicine.

Read more

Portfolio

See all items

Contact

Fagron is active in the growing market of personalized medicine, always looking for new strategic opportunities

Contact Form